NCT02310971View on ClinicalTrials.gov

Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

February 28, 2015

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions

Pancreatic Carcinoma Stage IPancreatic Carcinoma Stage II

Interventions

BIOLOGICAL

CVac

Cvac will be administered via intradermal injection, every 4 weeks for the first 3 doses and thereafter every 12 weeks for 3 additional doses for a total of 6